References
- McDonald G B, Sharma P, Hackman R C, Meyers J D, Thomas E D. Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology 1985; 88: 1111–1117
- Wheeler R R, Peacock J E, Jr, Cruz M J, Richter J E. Esophagitis in the immunocompromised host: Role of esophagoscopy in diagnosis. Rev Infect Dis 1987; 9: 88–96
- Wade J C, Newton B, McLaren C, Fluornoy N, Keeney R E, Meyers J D. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation. Ann Intern Med 1982; 96: 265–269
- Mitchell C D, Gentry S R, Boen J R, Bean B, Groth K E, Balfour H H, Jr. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet 1981; 1: 1389–1392
- Brady C E, Hover A R. Esophagitis in immunocompromised patients: A diagnostic challenge. South Med J 1983; 76: 1538–1541
- Rosen P, Hajdu S. Cytomegalovirus inclusion disease at autopsy of patients with cancer. Am J Clin Pathol 1971; 55: 749–756
- Meyers J D, Wade J C, Mitchell C D, et al. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med 1982; 73(Suppl)229–235
- Hirsch M S, Schooley R T. Treatment of herpes virus infections. N Engl J Med 1983; 309: 963–970, 1034–1039
- Creger R J, Fox R M, Lazarus H M. Infusion of high doses of undiluted etoposide through central venous catheters during preparation for bone marrow transplantation. Cancer Invest 1990; 8: 13–16
- Lazarus H M, Crilley P, Ciobanu N, et al. High dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma. J Clin Oncol 1992; 10: 1682–1689
- Lazarus H M, Spitzer T R, Creger R J. Phase I trial of high-dose etoposide, high-dose cisplatin, and reinfusion of autologous marrow for transplantation. Am J Clin Oncol 1990; 13: 107–112
- Lazarus H M, Magalhaes-Silverman M, Fox R M, Creger R J, Jacobs M. Contamination during in vitro processing of bone marrow for transplantation: Clinical significance. Bone Marrow Transplant 1991; 7: 241–246
- Lazarus H M, Creger R J, Gerson S L. Infectious emergencies in oncology patients. Semin Oncol 1989; 16: 543–560
- Saral R, Burns W H, Laskin O L, Santos G W, Lietman P S. Acyclovir prophylaxis of herpes-simplex virus infections: A randomized double-blind trial in bone marrow transplant recipients. N Engl J Med 1981; 305: 63–67
- Goodman J L, Winston D J, Greenfield R A, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845–851
- Bianco J A, Pepe M S, Higano C, et al. Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients. Am J Med 1990; 89: 134–136
- Norfleet R G, Mitchell P D, Mulholland D D, Philo J. Does bacteremia follow upper gastrointestinal endoscopy?. Am J Gastroenterol 1981; 76: 420–422
- Greene W H, Moody M, Hartley R, et al. Esophagoscopy as a source of Pseudomonas aeruginosa sepsis in patients with acute leukemia: The need for sterilization of endoscopes. Gastroenterology 1974; 67: 912–919
- Botoman V A, Surawicz C M. Bacteremia with gastrointestinal endoscopic procedures. Gastrointest Endosc 1986; 32: 342–346
- Baltch A L, Buhae I, Agarwal A, et al. Bacteremia after upper gastrointestinal endoscopy. Arch Intern Med 1977; 137: 594–597
- Shull H J, Greene B M, Allen S D, et al. Bacteremia with upper gastrointestinal endoscopy. Ann Intern Med 1975; 83: 212–214